Properties of a new penicillinase type produced by Bacteroides fragilis.

Antimicrobial Agents and Chemotherapy
K SatoS Mitsuhashi

Abstract

A highly penicillin-resistant strain of Bacteroides fragilis, strain GN11499, was found among 80 clinical isolates of the B.fragilis group and appears to produce a new type of penicillinase. Penicillinase activity was detected in crude extracts and had a specific activity of 0.25 U/mg of protein. About 20% of the enzyme was released into the surrounding medium during growth. The enzyme hydrolyzed ampicillin and cloxacillin more rapidly than it did penicillin G, carbenicillin, and cephaloridine. Relative rates in a crude extract with penicillin G as 100 were ampicillin, 357; carbenicillin, 57; cloxacillin, 271; and cephaloridine, 71. Enzyme activity was inhibited by clavulanic acid, CP-45, 899, N-formimidoyl thienamycin, cefoxitin, moxalactam, and p-chloromercuribenzoate. The enzyme had a molecular weight of approximately 41,500 and an isoelectric point of 6.9. Penicillinase production and tetracycline resistance were transferred from B.fragilis GN11499 to two susceptible strains of B.fragilis and Bacteroides vulgatus by filter mating.

References

May 1, 1976·Antimicrobial Agents and Chemotherapy·B OlssonT Wadström
Mar 1, 1978·Antimicrobial Agents and Chemotherapy·M L Britz, R G Wilkinson
Mar 1, 1978·Antimicrobial Agents and Chemotherapy·F P TallyS L Gorbach
Nov 1, 1978·Antimicrobial Agents and Chemotherapy·H C Neu, K P Fu
Aug 1, 1979·Antimicrobial Agents and Chemotherapy·H C NeuP Aswapokee
Dec 1, 1979·Antimicrobial Agents and Chemotherapy·N MatsubaraS Mitsuhashi
Apr 1, 1979·Plasmid·R A WelchF L Macrina
Oct 1, 1976·Antimicrobial Agents and Chemotherapy·V L Sutter, S M Finegold
Jun 1, 1974·The Biochemical Journal·S G Waley
Jan 1, 1973·Advances in Microbial Physiology·M H Richmond, R B Sykes
Mar 1, 1973·Antimicrobial Agents and Chemotherapy·V E Del Bene, W E Farrar
Jun 11, 1971·Annals of the New York Academy of Sciences·R P Novick, D Bouanchaud
Oct 1, 1968·Journal of Bacteriology·G PinkusA I Braude
Apr 1, 1980·Antimicrobial Agents and Chemotherapy·K SatoS Mitsuhashi
Dec 24, 1955·British Medical Journal·L P GARROD
May 1, 1962·The Biochemical Journal·R P NOVICK

❮ Previous
Next ❯

Citations

Jun 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P MastrantonioA Sebastianelli
Apr 1, 1983·Antimicrobial Agents and Chemotherapy·F P TallyC L Pierson
Dec 1, 1983·Antimicrobial Agents and Chemotherapy·A YotsujiS Mitsuhashi
Dec 1, 1983·Antimicrobial Agents and Chemotherapy·G J CuchuralJ W Mayhew
Jun 1, 1985·Antimicrobial Agents and Chemotherapy·K TunérC E Nord
May 1, 1986·Antimicrobial Agents and Chemotherapy·G J CuchuralM H Malamy
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·G J CuchuralF P Tally
Apr 1, 1987·Antimicrobial Agents and Chemotherapy·A E De Almeida, M De Uzeda
Mar 1, 1989·Antimicrobial Agents and Chemotherapy·K Bush
Aug 1, 1989·Antimicrobial Agents and Chemotherapy·T KesadoC E Nord
Jan 1, 1992·Antimicrobial Agents and Chemotherapy·K LeeY Chong
Apr 1, 1994·Antimicrobial Agents and Chemotherapy·K E AldridgeD D Schiro
Jun 1, 1995·Antimicrobial Agents and Chemotherapy·K BushA A Medeiros
Jan 1, 1984·Scandinavian Journal of Infectious Diseases. Supplementum
Feb 1, 1996·Journal of Chemotherapy·M Hedberg, C E Nord
Nov 27, 2002·Journal of Neurosurgery·Michael J LinkJohn M Tew
Oct 1, 1991·Clinical Microbiology Reviews·H M Wexler
Apr 1, 1996·Antimicrobial Agents and Chemotherapy·P MastrantonioP Spigaglia

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Related Papers

Antimicrobial Agents and Chemotherapy
F P TallyS L Gorbach
Antimicrobial Agents and Chemotherapy
G J CuchuralJ W Mayhew
Antimicrobial Agents and Chemotherapy
A YotsujiS Mitsuhashi
© 2021 Meta ULC. All rights reserved